Ocuphire Pharma (OCUP) Earnings Date, Estimates & Call Transcripts

$1.68
-0.05 (-2.88%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(Mar. 8)
-$0.21 Missed By -$0.14
Consensus EPS
(Mar. 8)
-$0.07
Skip Charts & View Estimated and Actual Earnings Data

OCUP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OCUP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ocuphire Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.18)($0.18)($0.18)
Q2 20241($0.29)($0.29)($0.29)
Q3 20241($0.29)($0.29)($0.29)
Q4 20241($0.29)($0.29)($0.29)
FY 20244($1.05)($1.05)($1.05)

OCUP Earnings Date and Information

Ocuphire Pharma last announced its quarterly earnings data on March 8th, 2024. The reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.14. The company earned $1.69 million during the quarter, compared to analyst estimates of $3.47 million. Ocuphire Pharma has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for Ocuphire Pharma are expected to grow in the coming year, from ($1.16) to ($0.52) per share. Ocuphire Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.

Ocuphire Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2024
Estimated)
------- 
3/8/2024Q4 2023($0.07)($0.21)($0.14)($0.21)$3.47 million$1.69 million
11/13/2023Q3 2023($0.32)$0.25+$0.57$0.25$2.00 million$11.94 million
8/11/2023Q2 2023($0.23)($0.24)($0.01)($0.24)-$3.67 million
5/15/2023Q1 2023($0.24)($0.28)($0.04)($0.28)-$1.75 million
3/30/2023Q4 2022$1.11$1.58+$0.47$1.58$35.00 million$39.85 million
11/4/2022Q3 2022($0.30)($0.22)+$0.08($0.22)--
8/12/2022Q2 2022($0.37)($0.25)+$0.12($0.25)--
5/13/2022Q1 2022($0.33)($0.35)($0.02)($0.35)--
3/24/2022Q4 2021($0.29)($0.35)($0.06)($0.35)--
11/12/2021Q3 2021($0.36)($0.25)+$0.11($0.25)-$0.49 million
8/12/2021Q2 2021($0.38)($0.52)($0.14)($0.52)-$0.10 million

Ocuphire Pharma Earnings - Frequently Asked Questions

When is Ocuphire Pharma's earnings date?

Ocuphire Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on OCUP's earnings history.

Did Ocuphire Pharma beat their earnings estimates last quarter?

In the previous quarter, Ocuphire Pharma (NASDAQ:OCUP) missed the analysts' consensus estimate of ($0.07) by $0.14 with a reported earnings per share (EPS) of ($0.21). Learn more on analysts' earnings estimate vs. OCUP's actual earnings.

How much revenue does Ocuphire Pharma generate each year?

Ocuphire Pharma (NASDAQ:OCUP) has a recorded annual revenue of $19.05 million.

How much profit does Ocuphire Pharma generate each year?

Ocuphire Pharma (NASDAQ:OCUP) has a recorded net income of -$9.99 million. OCUP has generated -$0.49 earnings per share over the last four quarters.

What is Ocuphire Pharma's EPS forecast for next year?

Ocuphire Pharma's earnings are expected to grow from ($1.16) per share to ($0.52) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:OCUP) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners